Aging Populations And Digital Health Will Accelerate Biologics Adoption
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 18 Analysts
Published
04 Jun 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
€255.00
23.8% undervalued intrinsic discount08 Aug
€194.30
1Y
26.7%7D
5.3%